Kruse Bo has filed 8 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 28629 shares of Y-mAbs Therapeutics, Inc. ($YMAB) on May 30, 2024.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 30, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Kruse Bo | EVP, CFO, SECRY & TREAS. | M | Common Stock | 28629 | $2.00 | 239,506.0000 | 43,779,456 | 13.58% | 0.07% |
| May 30, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Kruse Bo | EVP, CFO, SECRY & TREAS. | S | Common Stock | 28629 | $12.03 | 210,877.0000 | 43,779,456 | 11.95% | 0.07% |
| May 31, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Kruse Bo | EVP, CFO, SECRY & TREAS. | M | Common Stock | 31371 | $2.00 | 242,248.0000 | 43,779,456 | 14.88% | 0.07% |
| May 31, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Kruse Bo | EVP, CFO, SECRY & TREAS. | S | Common Stock | 31371 | $12.07 | 210,877.0000 | 43,779,456 | 12.95% | 0.07% |
| May 30, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Kruse Bo | EVP, CFO, SECRY & TREAS. | M | Employee Stock Option (right to buy) | 28629 | $0.00 | 271,371.0000 | 43,779,456 | 9.54% | 0.07% |
| May 31, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Kruse Bo | EVP, CFO, SECRY & TREAS. | M | Employee Stock Option (right to buy) | 31371 | $0.00 | 240,000.0000 | 43,779,456 | 11.56% | 0.07% |
| Jan. 18, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Kruse Bo | EVP, CFO, SECRY & TREAS. | A | Common Stock | 18100 | $0.00 | 210,877.0000 | 43,645,388 | 9.39% | 0.04% |
| Jan. 18, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Kruse Bo | EVP, CFO, SECRY & TREAS. | A | Employee Stock Option (right to buy) | 108900 | $0.00 | 108,900.0000 | 43,645,388 | 9999.99% | 0.25% |